Objectives: To evaluate the reported literature on the use of stem cells or growth factors for post extraction treatment of the alveolar bone. Material and Methods: A NCBI PubMed and PubMed Central databases search was conducted between September 2010 and August 2018, to identify animal or clinical studies reporting the clinical, radiographical and/or histological outcomes of socket preservation techniques after applying mesenchymal stem cells or growth factors. Only studies published in English language in the last 10 years were included in the study. Results: Eleven studies were identified fulfilling the inclusion criteria. They evaluate a total of 386 post extraction sockets. The main tested materials identified in the current review were bone morphogenetic protein-2 -3 studies and mesenchymal stem cells -3 studies. Other comparators were bone morphogenetic protein-9, platelet-derived growth factor-BB homodimers and bone marrow. Overall evaluation indicate positive results for all test groups showing differences in final socket width between 0.64 and 1.28 mm favouring the test groups. Histologically, no particular differences are detected between test and control groups. Most of the studies present low risk of bias. Conclusions: In general, the use of mesenchymal stem cells or bioactive osteogenic molecules favours bone regeneration after tooth extraction, as evaluated clinically, radiographically and histologically. However, specific differences that support particular recommendations are still unclear in light of the current published evidence. Future studies should include the standardization of the mesenchymal stem cells selection and purification as well as dosage and delivery methods of bioactive molecules.
INTRODUCTION
Tooth extraction is possibly the most commonly performed surgical procedure in dentistry. Following the extraction of teeth, the alveolar bone losses its supportive function. As a consequence, it is progressively resorbed [1] . Thus, in many cases, remaining bone volume may not be sufficient to properly support the placement of a dental implant in the correct three-dimensional position. Because of this, in recent years, filling of the socket with different biomaterials has been promoted [2] . Also, in cases when alveolar bone is lost, its reconstruction after the extraction of the tooth has been investigated. Regardless of the method and the biomaterial used, some level of volume loss should be expected [3] . Thus, better materials and techniques should be investigated. Bone regeneration, as previously reviewed [4] , "requires the migration of specific cells to the healing area to proliferate and provide the biological substrate for the new tissue to grow". Cell migration, proliferation and differentiation is regulated by a number of soluble factors in coordination with extracellular signals, three-dimensional support and scaffolds and with the correct blood supply. A number of scaffolds have been proposed in the literature. However, the bioactive molecules and cells with differentiation potential are still more un-used [4] . Stem cells have the capacity to self-renew and, under the adequate stimuli, to differentiate into multiple celltypes, depending on their potential. In the particular case of mesenchymal stem cells (MSC), they have the potential to differentiate into adipo-, chondro-and osteo-genic tissues [5] . Thus, they have been studied for a great number of regenerative cell-based therapies. This includes regeneration of maxillofacial bone. MSC can be obtained from a number of different adult tissues, including many in the oral cavity [6] , mainly the bone marrow, dental pulp and periodontal ligament [7] [8] [9] . MSC from the oral cavity have demonstrated all the characteristics to consider a cell population as a MSC: growth kinetics, cumulative population doubling, total number of passages, clonogenicity, expression of surface markers and stemness genes and multilineage differentiation potential [6] . Because of this, they have gained interest from the scientific community to be used locally in maxillofacial defects. Although Sonoyama et al. [10] discussed the different differentiation potential of MSC from different origins, it must be noted that most properties are similar among MSC [11] . It should also be noted that before MSCs were proposed to be used for bone regeneration, growth factors and other bioactive molecules had been suggested [12] , including platelet derived growth factor (PDGF), fibroblast growth factor, insulingrowth factor and bone morphogenetic proteins (BMPs) [4] . Moreover, around the use of bioactive molecules, a plethora of techniques have been developed in order to reduce the dosage of the drug while improving its timely delivery [13, 14] . Thus, it is the aim of the current review to evaluate the use of mesenchymal stem cells and bioactive molecules for bone regeneration after tooth extraction.
MATERIAL AND METHODS Protocol and registration
This systematic literature reviews adheres to the PRISMA Statement [15] . The review protocol was registered before any search was conducted in an international prospective register of systematic reviews (PROSPERO) in which the methodology and inclusion and exclusion criteria were specified and documented in advance. The protocol can be accessed at: https://www.crd.york.ac.uk/PROSPERO/display_ record.php?RecordID=136092 with the registration number: CRD42019136092.
Focus question
The following focus question was developed according to the problem, intervention, comparison, and outcome (PICO) design (Table 1) . What biomaterials in combination with stem cells and growth factors are used for socket preservation after the tooth extraction and which of those show the best results regarding alveolar dimensional changes and quality of newly formed bone?
Types of publications
Studies on humans or animals that had been published in the English language were included in the review. Other type of reports, such as abstracts, PhD theses, literature reviews, editorials and letters were excluded. Publication time was established between April 7, 2010 and January 27, 2018.
Types of studies
The review included clinical, comparative, prospective, cohort and case series studies on various extraction socket preservation procedures using 
Information sources
The search strategy was introduced into electronic databases (NCBI PMC and PubMed) and supplemented by hand searches in dental implant related journals, particularly "Clinical Oral Implants Research", "International Journal of Oral and Maxillofacial Surgery", "European Journal of Oral Implantology", "Journal of Clinical Periodontology", "Journal of Oral and Maxillofacial Implants", "Journal of Periodontology", "Journal of Oral and Maxillofacial Surgery", and "The International Journal of Periodontics and Restorative Dentistry". In addition, the references of the included relevant studies were screened to find potential relevant publications not included in the previous search to improve the sensitivity.
Search
The databases were explored through advanced searches. The following search inquiries were used: "extraction socket" OR ''extraction socket'' AND ''growth factors'' OR ''extraction socket'' AND ''stem cells'' OR ''extraction socket'' AND ''mesenchymal stem cells'' OR ''alveolar ridge preservation'' OR ''alveolar ridge preservation'' AND ''stem cells'' OR ''alveolar ridge preservation'' AND ''mesenchymal stem cells'' OR ''socket preservation'' OR ''socket preservation'' AND ''stem cells'' OR ''socket preservation'' AND ''mesenchymal stem cells''. These keywords were selected in order to collect as much relevant references as possible.
Selection of studies
Two reviewers (MP and MP-M) evaluated the resulting articles according to clear criteria for inclusion and exclusion. The reviewers made decisions and set differences through discussion. If consensus about inclusion or exclusion could not be reached, a third party (an experienced senior reviewer, PG-M) was consulted and his decision adopted.
Inclusion and exclusion criteria
Studies were included if they fulfil the following criteria as follows:
• Investigated changes of bone dimensions or quality after preservation, regeneration or tissue formation using stem cells and/or growth factors after tooth extraction; • Human or animal studies and clinical trials, comparative studies, prospective studies, feasibility trials, cohort studies and case series studies;
• At least 1 month of follow-up after the extraction and following procedure; • If before careful reading the study could not be excluded. If articles presented any of the following, they were excluded from the current review:
• Studies that evaluated bone lateral augmentation, sinus lifts or other type of bone grafting or regeneration; • Studies where the effect of stem cells and growth factors influence in post extraction socket regeneration could not be analysed from the data; • Studies that presented unclear data;
• Studies older than 10 years;
• Articles written not in English language.
Sequential search strategy
After the initial literature search, case reports, review articles and other irrelevant publications were eliminated by reading the titles of the studies. Then, abstracts of the pre-selected studies were evaluated to further exclude irrelevant publications. The final stage of article selection involved reading the full texts , and based on the inclusion and exclusion criteria defined above, confirm each study's eligibility.
Data extraction
The data from different studies were registered from studies according to the interests of the current review, as listed below.
Data items
Data from the included articles were collected and organised in in columns with the following information: author and year, sample size for this outcome/measure, defect location/defect type, measuring method (clinical, histological, radiography), test groups, surgical protocol, results, and outcome.
Assessment of methodological quality
As part of the data extraction process, two review authors assessed the risk of bias of the included studies. To do so, the recommended approach for assessing risk of bias in studies included in Cochrane reviews was used [44] .
Synthesis of results
As mentioned, tables were prepared with the fields included as data items.
Statistical analysis
Due to the high heterogeneity between the studies, no meta-analysis could be performed. Thus, only a descriptive evaluation is presented.
RESULTS

Study selection
Article review, selection and data extraction were conducted as shown in the PRISMA flow diagram ( Figure 1 ). As it can be observed, the initial search located a total of 2342 articles. Of those, 408 were identified as potentially relevant articles by the screening of the article titles. The abstracts were read and from there, 39 publications were selected for possible inclusion. Finally, these 39 publications were evaluated in full-text. After applying the inclusion and exclusion criteria, 11 articles fulfil the predefined criteria and were, therefore, incorporated in the systematic review. There are no reasons for exclusion. Excluded full text articles should be included into references list. If it is big number, so show most often reasons and numbers how much for each reason excluded. Eight of them are clinical trials (extraction sockets number: 295), two animal studies (extraction sockets number: 44), one prospective pilot clinical study (extraction sockets number: 47). Total extraction sockets number: 386.
Study characteristics
The included studies compared ridge dimension changes and bone formation considering the number of extraction sockets and clinical, radiological or histological parameters.
Influence of MSC and growth factors for extraction socket preservation Clinical/radiographical measurements
Changes of post extraction sockets dimensions were metered in six studies. Three of them for sockets preservation as test group used BMP-2 [45] [46] [47] and collagen sponge [46] , demineralized bone [45] or hydroxyapatite [47] as matrix. One study used MSC [48] and collagen membrane as a matrix, another one used BMP-9 [49] and collagen membrane, and in one study sockets were filled with bone marrow without any matrix [50] . The difference of socket width between test and control groups varies from 0.64 to 1.279 mm. Despite the heterogeneity of studies, all test groups showed statistically significant better results comparing to control groups or unassisted healing (Table 1) .
Histological measurements
The percentage of new bone or connective tissue that had invaded the former space of the root was examined in five articles [51] [52] [53] [54] [55] . In these studies platelet-derived growth factor-BB homodimers (PDGF-BB) [51] , BMP-2 [52] , bovine bone + poly (L-lactide-coE-caprolactone), PDGF-BB [53] , and MSC [55] Moreover, one article demonstrates that usage of recombinant human PDGF-BB produced less residual bone graft material, indicating more rapid turnover of bone graft during early healing (8 weeks) [51] ( Table 2) .
Quality assessment
The majority of the included studies have an unknown risk of bias for one or more key domains [46, [48] [49] [50] 52, 54] . Five studies [45, 47, 51, 53, 55] were classified as low risk of bias for all key domains (Table 3 ).
DISCUSSION
The current review has found a number of studies analysing the use of MSC and/or bioactive molecules for socket preservation/regeneration. NCBI PMC and PubMed database advanced search: -Search items: "extraction socket" OR "extraction socket" AND "growth factors" OR "extraction socket" AND "stem cells" OR "extraction socket" AND "mesenchymal stem cells" OR "alveolar ridge preservation" OR "alveolar ridge preservation" AND "stem cells" OR "alveolar ridge preservation" AND "mesenchymal stem cells" OR "socket preservation" OR "socket preservation" AND "stem cells" OR "socket preservation" AND "mesenchymal stem cells". -Investigated changes of bone dimensions/quality after regeneration/formation using stem cells and/or growth factors after tooth extraction; -All human or animal studies and clinical trials, cohort studies, case-control studies, and case series studies; -A follow up-time period of at least 1 month after the extraction and following procedure; -Could not be excluded before careful reading; All extraction sockets were filled with deproteinized bovine bone mineral and covered with collagen membrane loaded with: 1. sterile saline as a control; 2. 20 μg of rhBMP-9; 3. 4 μg of rhBMP-9; 4. rhBMP9
Premolars were hemi sected, and the distal roots were extracted. The canal of the mesial roots was then reamed and filled with gutta-percha. Full thickness flap was elevated, and the buccal bone was removed.
rhBMP-9 defects showed higher values of bone (P = 0.024), bone marrow (P = 0.044), and total augmentation volume (P = 0.033) than the rhBMP2 (20 μg) or control sites. Highest bone area was found in rhBMP-9 defects (P = 0. Most of them indicate, as it could be arguably expected, because of publication bias, a noninferiority of the test group under study, regardless of the specific agent and the comparator control group. Post extraction sockets are usually selfcontained and small defects. Thus, the potential advantages of additional products, beside those for maintaining the space (traditional particulated bone grafts) and excluding soft tissue invasion (guided tissue regeneration membranes), might be limited. This does not necessarily mean that they are not useful though. On the contrary, it reflects a lack of standardization in the clinical application of these methods. As previously reviewed [4] , the application of MSCs for bone regeneration within the oral cavity varies tremendously in the observation period, specific therapeutic application, carrier, origin of the MSCs and method of purification of such cells. Because of this diversity, comparison among studies is complicated. Noteworthy, the current study found only three studies using MSC for bone regeneration after tooth extraction. In all three cases, MSC were obtained from the iliac crest. However, neither the carrier nor the processing method was standard in all cases: one used an automatic subculturing and purification process for 14 days and implanted the cells through a collagen sponge [55] , other manually subcultured the cells during 10 days and implanted them in a collagen membrane [48] and the other extracted the bone marrow and applied it directly with no subculture nor purification [50] . Because of this, in addition to other differences in the evaluation method, specific differences in results might be explained. In any case, in all three cases, positive outcomes were reported. On the other hand, bioactive molecules that regulate the process of MSC differentiation also report positive results in all cases under review in the current manuscript. The most analysed growth factor is a member of the transforming growth factor-ß superfamily, the bone morphogenetic proteins, particularly BMP-2 [14] . BMPs can induce angiogenesis, synthesis of the extracellular matrix, chondrogenesis and osteogenesis. BMP-2 is probably the most active inductor of bone formation, being able to compensate for the absence of other members of the family [56] . The natural activity of BMP-2 is initiated after bone resorption, when the resorptive activity of osteoclasts releases the BMP from the matrix [14] . However, the reported use of BMP-2 for bone regeneration also lacks from standardization among studies. One of the main issues identified in previous and current reports is the dosage of the recombinant protein and the delivery method. Either absorbable collagen sponges [46, 52] or mineralized grafts [45, 47, 49] have been identified as carriers in the current review. In both cases, the addition of the protein seems to induce better outcomes. Similar results have been indicated in previous reviews, in which particular doses were recommended (1.5 mg/ml) [20] . In more recent years, another step has been taken into the use of this kind of active molecules. A protein is usually rapidly deactivated by denaturalization. Also, proper bioactivity requires the protein to be active at a specific time. Thus, protecting the activity of the protein by means of poly-lacticco-glycolic acid nanoparticles has been proposed. Moreover, a controlled release may also be beneficial for the success of these techniques [13] . However, so far, these techniques have not yet been applied clinically.
Other bioactive molecules may also provide positive results, including but not limited to those identified in the current review, such as PDGF-BB. PDGF activity had been initially analysed for periodontal tissue regeneration [57] for its capacity to induce not only cell differentiation but also, and mainly, new vascular development. Thus, its application for bone regeneration might also be useful. The current review has not found sufficient evidence to support clear indications about this molecule, but in turn, negative results from one of the studies in which it was evaluated [51] . In summary, the current review presented an overview of different studies showing the outcomes after using either MSC or regulatory molecules for bone regeneration in the context of after-tooth-extraction therapies. In view of the current review and according to previous reports [21] , it must be concluded that beside the positive reported outcomes, no clear conclusion nor recommendation on the use of these techniques can be made because of the different methods applied in the studies under analysis.
CONCLUSIONS
Stem cells and growth factors usage for alveolar ridge preservation are promising for future daily clinical practice. Today, these methods need to be standardized and based on more scientific data.
Recommendations for future studies should include the standardization of the mesenchymal stem cells selection and purification as well as a specific effort into conducting comparable studies in the current topic.
